SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fischer Chemic informs about outcome of independent director meet

26 Mar 2022 Evaluate

Pursuant to the provisions of Regulation 25(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 and Schedule IV of the Companies Act, 2013, Fischer Chemic has informed that the Independent Director of the Company in their meeting held on Saturday, 26th March, 2022 has: Reviewed the performance of Non-Independent Directors & the Board as a whole, Reviewed the performance of the Chairperson of the company, taking into account the views of Executive Directors and Non-Executive Directors and Assessed the quality, quantity and timeliness of flow of information between the management of the company and the Board.

The above information is a part of company’s filings submitted to BSE.

Fischer Medical Share Price

40.80 0.22 (0.54%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 234.90
Adani Enterprises 2218.35
Amrapali Industries 17.53
Rashi Peripheral 455.25
PDS 301.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×